Sofosbuvir-Daclatasvir Is Suboptimal in Patients with Genotype 2 Chronic Hepatitis C Infection: Real-life Experience from the HEPATHER ANRS CO22 Cohort
Domains
Life Sciences [q-bio]Origin | Files produced by the author(s) |
---|
_ |
Origin | Files produced by the author(s) |
---|
Gestionnaire HAL 4 Sorbonne Université : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03704126
Submitted on : Tuesday, August 30, 2022-1:36:45 PM
Last modification on : Thursday, November 7, 2024-2:21:19 PM